Lung Cancer & COVID-19 Webinar.

December 20, 2020

Author: Acteropharma

Regarding the Importance of experience sharing about Lung cancer patients with COVID-19 complications, a multidisciplinary virtual Meeting was held on December 3rd 2020, with the topic of “Lung Cancer & COVID19” with the presence of Dr. Khosravi (Medical Oncologists), Dr. Seifi (Medical Oncologists), Dr. Salimi (Medical Oncologists), Dr. Kiani (Pulmonologist), Dr. Naseri (Radio Oncologist), Dr. Bakhshayesh karam (Radiologist), Dr. Daneshvar (Thoracic Surgeon).

Erlotinib ACTe & Pemetrexed ACTe are two ACTERO’s products, which has a certain position in lung cancer treatment.

Last News

روز کارگر-EN-08
May 1, 2025

Author:

Acteropharma
International Labor Day is a global tribute to the unwavering will and tireless hands that shape the future. It is a meaningful occasion to honor those whose dedication, expertise, and commitment drive the engines of progress and prosperity.
the 9th International Radio-Oncology Congress
March 11, 2025

Author:

Acteropharma
From January 30 to February 1, the 9th International Radio-Oncology Congress was held with the aim of advancing scientific programs in the community and supporting the expansion of cancer research.
Ehsan-08
March 5, 2025

Author:

Acteropharma
For several years, in a commendable initiative aligned with this national tradition, March 4 has been designated as the National Day of Kindness and Generosity in our country’s official calendar.